Mechanisms of Ageing and Development 2000: Vol 116 Index

7 Pages·2000·1.1 MB·English

mechaniosf amgesin g
and development
Mechanisms of Ageing and Development
116 (2000) 219
www.elsevier.com/locate/mechagedev
Author index of volume 116
Asano, N._ 116, 155 Ingram, D.K. 116, 77 Roberts, S.B. 116, 157
Roth, G.S. 116, 77
Bejma, J. 116, 33 Jaszewski, R. 116, | Rottkamp, C.A. 116, 169
Besse, S. 116, 15 Ji, L.L. 116, 33
Bielinski, D. 116, 141 Joseph, J.A. 116, 141 Sayre, L.M. 116, 169
DUGES, Tv. 558, Se Schréder, H.C. 116, 193
Boucher, F. 116, 15 Kitani, K. 116, 63, 181 Shukitt-Hale. B. 116. 14]
ae : Smith, M.A. 116, 169
Carrillo, M.C. 116, 181 Laplanche, J.-L. 116, 193 Suh. Y. 116. 47
de Leiris, J. 116, 15 Majumdar, A.P.N. 116, |
Denisova, N.A. 116, 141 Maruyama, W. 116, 181 Tanaka, M. 116, 65
Tanguy, S. 116, 15
Morimitsu, Y. 116, 125
Fisher, D.R. 116, 141 Miller, W.E.G. 116, 193 Toufektsian, M.-C. 116, 15
Fujii, H. 116, 125
Fujishima, M. 116, 95 Nakagawa, Y. 116, 125 Uchida, K. 116, 125, 135
Naoi, M. 116, 181 Umegaki, H. 116, 77
Gong, J.-S. 116, 65 Nunomura, A. 116, 169 Ushijima, H. 116, 193
Hayashi, K. 116, 125 Ogata, E. 116, 103 Xiao, Z.-Q. 116, |
Heistad, D.D. 116, 95 Ohno, H. 116, 33
Hirai, K. 116, 169 Ooboshi, H. 116, 95
Yagi, K. 116, 65
Hollander, J. 116, 33 Ookawara, T. 116, 33
Horio, F. 116, 125 Osawa, T. 116, 125 Yamada, Y. 116, 65, 113
Yamamoto, T. 116, 181
Ibayashi, S. 116, 95 Park, S.C. 116, 47 Youdim, M. 116, 181
Ikari, H. 116, 77 Park, W.Y. 116, 47
Ikeda, K. 116, 103 Perry, G. 116, 169 Zhang, J. 116, 65
PIl: S0047-6374(00)00161-5

mechaniofs amgesin g
and development
Mechanisms of Ageing and Development
116 (2000) 221—224
www.elsevier.com/locate/mechagedev
Subject index of volume 116
Acetylcholine; Gene therapy: Parkinson’s dis- Apoptosis; Creutzfeldt-Jakob disease: Prion
ease; Huntington's disease; Motor performance: protein; Neurotoxicity; Oxidative stress; Cere-
Neurotransmitter receptor; Striatum: Memory: brospinal fluid; 14-3-3 protein; NMDA receptor:
Mutant mice 116, 77 Flupirtine; Memantine 116, 193
Activator protein-1 (AP-1); Ageing: Gene expres- Apoptosis; Neuroprotection; Parkinson’s disease:
sion; Nuclear factor-kB (NFKB):; Skeletal mus- Propargylamine; Rasagiline; | Mitochondrial
cle; Superoxide dismutase 116, 33 membrane potential 116, 181
Active vitamin D; Osteoporosis; Bone resorption; ATP synthase; Mitochondrial DNA; Longevity:
Bone formation 116, 103 Single nucleotide polymorphism; Centenarian;
NADH dehydrogenase 116, 65
Adenovirus; Gene therapy; Gene transfer; Nitric
oxide synthase; Stroke; Vector 116, 95 Body composition; Energy intake; Energy
metabolism; Aging: Anorexia 116, 157
Ageing; Activator protein-| (AP-1); Gene ex-
Bone formation; Active vitamin D; Osteoporosis:
pression; Nuclear factor-kKB (NFKB):; Skeletal
Bone resorption 116, 103
muscle; Superoxide dismutase 116, 33
Bone mineral density; Transforming growth fac-
Ageing; Fasting; Glycogenolysis: Glycolytic flux;
tor-B1l; = Polymorphism; Osteoporosis; Os-
Ischemic contracture 116, 15
teoarthritis; Postmenopausal women’ 116, 113
Aging: Colonic mucosa; Cyclins; Cyclin-depen-
Bone resorption; Active vitamin D; Osteoporosis:
dent kinases; p21*"'; p53; Retinoblas-
Bone formation 116, 103
toma 116, |
Cancer chemoprevention: Isothiocyanate;
Aging: Energy intake; Energy metabolism:
Wasabi; Platelet aggregation; Phase II enzyme:
Anorexia; Body composition 116, 157
Glutathione S-transferase 116, 125
Alzheimer disease; Oxidative stress: Neurofibril- Centenarian; Mitochondrial DNA; Longevity:
lary tangles 116, 169
Single nucleotide polymorphism; NADH dehy-
drogenase; ATP synthase 116, 65
Anorexia; Energy intake; Energy metabolism;
Aging: Body composition 116, 157 Cerebrospinal fluid; Creutzfeldt-Jakob disease:
Prion protein; Neurotoxicity; Apoptosis; Oxida-
Antioxidants; Prostaglandins; Glutathione S- tive stress; 14-3-3 protein; NMDA _ receptor:
transferase; Detoxification enzymes 116, 135 Flupirtine; Memantine’ 116, 193
PIL: S0047-6374(00)00162-7
Subject index of volume 116
Colonic mucosa; Aging; Cyclins; Cyclin-depen- Glutathione S-transferase; Prostaglandins;
dent kinases; p21“*"'; p53; Retinoblas- Detoxification enzymes; Antioxidants 116, 135
toma 116, |
Glycogenolysis; Ageing; Fasting; Glycolytic flux;
Creutzfeldt—Jakob disease; Prion protein; Neu- Ischemic contracture 116, 15
rotoxicity; Apoptosis; Oxidative stress; Cere-
brospinal fluid; 14-3-3 protein; NMDA receptor; Glycolytic flux; Ageing; Fasting; Glycogenolysis;
Flupirtine; Memantine 116, 193 Ischemic contracture 116, 15
Cyclin-dependent kinases; Aging; Colonic mu- Huntington’s disease; Gene therapy; Parkinson’s
cosa; Cyclins; p21“*"'; p53; Retinoblas- disease; Motor performance; Neurotransmitter
toma 116, | receptor; Striatum; Memory; Acetylcholine; Mu-
tant mice 116, 77
Cyclins; Aging; Colonic mucosa; Cyclin-depen-
dent kinases; p21“*"'; p53; Retinoblas- Ischemic contracture; Ageing; Fasting:
toma 116, | Glycogenolysis; Glycolytic flux 116, 15
Detoxification enzymes; Prostaglandins; Glu- Isothiocyanate: Wasabi; Platelet aggregation;
tathione S-transferase; Antioxidants 116, 135 Phase II enzyme; Glutathione S-transferase;
Cancer chemoprevention 116, 125
Dietary supplementation; Membranes; Receptors;
Polyphenolics 116, 141 Longevity; Mitochondrial DNA; Single nucle-
otide polymorphism; Centenarian; NADH dehy-
Energy intake; Energy metabolism; Aging; drogenase; ATP synthase 116, 65
Anorexia; Body composition 116, 157
Memantine; Creutzfeldt-Jakob disease; Prion
Energy metabolism; Energy intake; Aging; protein; Neurotoxicity; Apoptosis; Oxidative
Anorexia; Body composition 116, 157 stress; Cerebrospinal fluid; 14-3-3 protein;
NMDA receptor; Flupirtine 116, 193
Fasting; Ageing; Glycogenolysis; Glycolytic flux;
Ischemic contracture 116, 15 Membranes; Receptors; Dietary supplementa-
tion; Polyphenolics 116, 141
Flupirtine; Creutzfeldt-Jakob disease; Prion
protein; Neurotoxicity; Apoptosis; Oxidative
Memory; Gene therapy; Parkinson’s disease;
stress; Cerebrospinal fluid; 14-3-3 protein;
Huntington’s disease: Motor performance; Neu-
NMDA receptor; Memantine 116, 193
rotransmitter receptor; Striatum; Acetylcholine;
Mutant mice 116, 77
Gene expression; Activator protein-| (AP-1):
Ageing: Nuclear factor-kB (NFKB); Skeletal
Mitochondrial DNA; Longevity: Single nucle-
muscle; Superoxide dismutase 116, 33
otide polymorphism; Centenarian; NADH dehy-
drogenase; ATP synthase 116, 65
Gene therapy; Adenovirus; Gene transfer; Nitric
oxide synthase; Stroke; Vector 116, 95
Mitochondrial membrane potential; Apoptosis;
Neuroprotection; Parkinson’s disease: Propargy-
Gene therapy; Parkinson’s disease; Huntington’s lamine; Rasagiline 116, 181
disease; Motor performance; Neurotransmitter
receptor; Striatum; Memory; Acetylcholine; Mu- Motor performance; Gene therapy; Parkinson’s
tant mice 116, 77 disease; Huntington’s disease; Neurotransmitter
receptor; Striatum; Memory; Acetylcholine; Mu-
Gene transfer; Adenovirus; Gene therapy: Nitric tant mice 116, 77
oxide synthase; Stroke; Vector 116, 95
Mutant mice; Gene therapy; Parkinson’s disease:
Glutathione S-transferase: Isothiocyanate; Huntington’s disease: Motor performance; Neu-
Wasabi; Platelet aggregation; Phase II enzyme: rotransmitter receptor; Striatum; Memory;
Cancer chemoprevention 116, 125 Acetylcholine 116, 77
Subject index of volume 116 242933
NADH _ dehydrogenase; Mitochondrial DNA; Parkinson’s disease; Apoptosis; Neuroprotection:
Longevity; Single nucleotide polymorphism; Propargylamine; Rasagiline; Mitochondrial
Centenarian; ATP synthase 116, 65 membrane potential 116, 181
Neurofibrillary tangles; Alzheimer disease; Oxi- Parkinson’s disease; Gene therapy; Huntington’s
dative stress 116, 169 disease; Motor performance; Neurotransmitter
receptor; Striatum; Memory; Acetylcholine; Mu-
Neuroprotection; Apoptosis; Parkinson’s disease: tant mice 116, 77
Propargylamine; Rasagiline; Mitochondrial
membrane potential 116, 181 Phase II enzyme; Isothiocyanate; Wasabi:
Platelet aggregation; Glutathione S-transferase;
Neurotoxicity; Creutzfeldt—Jakob disease: Prion Cancer chemoprevention 116, 125
protein; Apoptosis; Oxidative stress; Cere-
brospinal fluid; 14-3-3 protein; NMDA receptor; Platelet aggregation; Isothiocyanate; Wasabi;
Flupirtine; Memantine 116, 193 Phase II enzyme; Glutathione S-transferase;
Cancer chemoprevention 116, 125
Neurotransmitter receptor; Gene _ therapy:
Parkinson’s disease; Huntington’s disease; Mo- Polymorphism; Transforming growth factor-B1:
tor performance; Striatum; Memory: Acetyl- Bone mineral density; Osteoporosis; Os-
choline; Mutant mice 116, 77 teoarthritis; Postmenopausal women 116, 113
Nitric oxide synthase; Adenovirus; Gene therapy; Polyphenolics; Membranes; Receptors; Dietary
Gene transfer; Stroke; Vector 116, 95 supplementation 116, 141
NMDA receptor; Creutzfeldt-Jakob disease: Postmenopausal women; Transforming growth
Prion protein; Neurotoxicity; Apoptosis; Oxida- factor-B1; Polymorphism; Bone mineral density;
tive stress; Cerebrospinal fluid; 14-3-3 protein; Osteoporosis: Osteoarthritis 116, 113
Flupirtine; Memantine 116, 193
Prion protein; Creutzfeldt-Jakob disease; Neu-
Nuclear factor-kB (NFB); Activator protein-| rotoxicity; Apoptosis; Oxidative stress; Cere-
(AP-1); Ageing: Gene expression; Skeletal mus- brospinal fluid; 14-3-3 protein; NMDA receptor;
Flupirtine; Memantine 116, 193
cle; Superoxide dismutase 116, 33
Osteoarthritis; Transforming growth factor-B1; Propargylamine; Apoptosis; Neuroprotection;
Polymorphism; Bone mineral density; Os- Parkinson’s disease; Rasagiline; Mitochondrial
teoporosis; Postmenopausal women 116, 113 membrane potential 116, 181
Osteoporosis; Active vitamin D; Bone resorp- Prostaglandins; Glutathione — S-transferase;
tion; Bone formation 116, 103 Detoxification enzymes; Antioxidants 116, 135
Osteoporosis; Transforming growth factor-B1; 14-3-3 protein; Creutzfeldt- Jakob disease; Prion
Polymorphism; Bone mineral density; Os- protein; Neurotoxicity; Apoptosis; Oxidative
teoarthritis; Postmenopausal women’ 116, 113 stress; Cerebrospinal fluid; NMDA receptor;
Flupirtine; Memantine 116, 193
Oxidative stress; Alzheimer disease: Neurofibril-
lary tangles 116, 169 p21“**'; Aging: Colonic mucosa; Cyclins; Cy-
clin-dependent kinases; p53; Retinoblas-
Oxidative stress; Creutzfeldt-Jakob disease; toma 116, |
Prion protein; Neurotoxicity; Apoptosis; Cere-
brospinal fluid; 14-3-3 protein; NMDA receptor: Rasagiline; Apoptosis; Neuroprotection; Parkin-
Flupirtine; Memantine 116, 193 son’s disease; Propargylamine; Mitochondrial
membrane potential 116, 181
53: Aggiinngg: Colonic mucosa: Cy5c lins: Cy.c lin-de-
pendent kinases; p21‘*"'; — Retinoblas- Receptors; Membranes; Dietary supplementa-
toma 116, | tion; Polyphenolics 116, 141
224 Subject index of volume 116
Retinoblastoma; Aging; Colonic mucosa; Cy- Stroke; Adenovirus; Gene therapy; Gene trans-
clins; Cyclin-dependent kinases; p21*"'; fer; Nitric oxide synthase; Vector 116, 95
p53 116,|
Superoxide dismutase; Activator protein-1 (AP-
1); Ageing; Gene expression; Nuclear factor-KB
Single nucleotide polymorphism; Mitochondrial
(NF«B); Skeletal muscle 116, 33
DNA; Longevity; Centenarian; NADH dehy-
drogenase; ATP synthase 116, 65
Transforming growth factor-B1; Polymorphism;
Bone mineral density; Osteoporosis; Os-
Skeletal muscle: Activator protein-] (AP-1);
teoarthritis; Postmenopausal women 116, 113
Ageing; Gene expression; Nuclear factor-xB
(NFKxB); Superoxide dismutase 116, 33
Vector; Adenovirus; Gene therapy; Gene trans-
fer; Nitric oxide synthase; Stroke 116, 95
Striatum; Gene therapy; Parkinson’s disease;
Huntington’s disease; Motor performance; Neu- Wasabi; Isothiocyanate; Platelet aggregation;
rotransmitter receptor; Memory: Acetylcholine; Phase II enzyme; Glutathione S-transferase;
Mutant mice 116, 77 Cancer chemoprevention 116, 125